financetom
Business
financetom
/
Business
/
Nutanix Insider Sold Shares Worth $1,126,515, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nutanix Insider Sold Shares Worth $1,126,515, According to a Recent SEC Filing
Jun 3, 2025 2:24 PM

05:07 PM EDT, 06/03/2025 (MT Newswires) -- Steven J Gomo, Director, on May 30, 2025, sold 15,000 shares in Nutanix ( NTNX ) for $1,126,515. Following the Form 4 filing with the SEC, Gomo has control over a total of 57,896 Class A common shares of the company, with 3,646 shares held directly and 54,250 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1618732/000095017025081089/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Royal Bank of Canada Ratings Affirmed by Fitch
Royal Bank of Canada Ratings Affirmed by Fitch
Jun 12, 2024
10:54 AM EDT, 06/12/2024 (MT Newswires) -- Fitch Ratings on Tuesday affirmed its long- and short-term issuer default ratings at AA- and F1+ for Royal Bank of Canada ( RY ) and its New York Branch respectively The rating outlook is stable. Also, Fitch affirmed the long- and short-term issuer default ratings for its subsidiary City National Bank at A+...
Simulations Plus Acquires Pro-ficiency For $100 Million
Simulations Plus Acquires Pro-ficiency For $100 Million
Jun 12, 2024
10:54 AM EDT, 06/12/2024 (MT Newswires) -- Simulations Plus ( SLP ) said Wednesday it acquired Pro-ficiency and its units from QHP Capital and minority shareholders for about $100 million in cash. The company said it is funding the transaction with existing cash and investment resources. Pro-ficiency provides simulation-enabled performance and solutions for clinical and commercial drug development. Simulations Plus...
Manulife Financial's Subordinated Debenture Due 2034 Assigned
Manulife Financial's Subordinated Debenture Due 2034 Assigned "A-" Rating by S&P
Jun 12, 2024
10:59 AM EDT, 06/12/2024 (MT Newswires) -- S&P Global Ratings said Tuesday that it assigned an A- rating to Manulife Financial's ( MFC ) issuance of a fixed-rate subordinated debenture due 2034. The company plans to use the proceeds for general corporate purposes, including investment in subsidiaries and potential future redemptions of existing securities. MFC's financial leverage and fixed-charge coverage...
Perspective Therapeutics  to Join Russell 3000 Index on July 1
Perspective Therapeutics to Join Russell 3000 Index on July 1
Jun 12, 2024
10:57 AM EDT, 06/12/2024 (MT Newswires) -- Perspective Therapeutics ( CATX ) said Wednesday it expects to join the Russell 3000 Index when the market opens on July 1, citing an updated list of additions posted on June 10. The company said it will be added to the all-cap Russell 3000 Index and an automatic spot in the large-cap Russell...
Copyright 2023-2026 - www.financetom.com All Rights Reserved